About

Mission Statement

Our mission is to reduce pain and improve health with psychedelic medicines. The Psychedelics & Pain Association (PPA) works to advance research, understanding, awareness and access to psychedelic medicines for the treatment of chronic pain, including headache disorders, autoimmune diseases, inflammatory conditions, mitochondrial dysregulation, spinal cord damage and traumatic brain injuries. PPA is a collaboration between Psychedelics Today, REMAP Therapeutics, and Clusterbusters, and it has received generous seed funding from The RiverStyx Foundation. All of the leaders of PPA are either directly or indirectly impacted by chronic pain.

Why PPA?

There is a robust ecosystem of funding, research and utilization support for psychedelics for the treatment of mental health. We need to start building the same support structures for psychedelics and the improved management of pain.

We are entering a new era of pain management — psychedelic medicines have the potential to offer relief across many pain categories.

Our Team

Court Wing

Court Wing

Cofounder

Bio
Joe Moore

Joe Moore

Cofounder

Bio
Bob Wold

Bob Wold

Cofounder

Bio
Kevin Lenaburg

Kevin Lenaburg

Executive Director

Bio
Eileen Brewer

Eileen Brewer

Advisor

Bio
Magali Brecke

Magali Brecke

Advisor

Bio
Joel Castellanos, MD

Joel Castellanos, MD

Advisor

Bio